Work

Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers

Year: 2015

Type: review

Source: CNS Drugs

DOI: 10.1007/s40263-015-0284-5

Authors: Megan M. Yardley, Michael M. Mirbaba, Lara A. Ray

Institution: University of California, Los Angeles

Language: English

Topic: Smoking Behavior and Cessation

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, National Center for Research Resources

Awards: Modeling alcohol reward and reinforcement in the human laboratory, Clinical assessment of ivermectin as a therapeutic agent to reduce alcohol intake, Neuroimaging probes of medication response in smokers, G3488532273, Combining varenicline and naltrexone for smoking cessation and drinking reduction, General Clinical Research Center, Development of Ibudilast as a Novel Treatment for Alcoholism

OpenAlex ID: W2208280703

FWCI: 0.245

Cites: 128

Cited by: 13

Related to: 10